BIRC5 and non-small cell lung carcinoma: For instance, as high expression of apoptosis inhibitors, survivin is significantly favorable for survival in patients with non-small-cell lung carcinoma (NSCLC), and up-regulation of Fas might also indicate a favorable prognosis in NSCLC with stage III disease [218,219].